Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. - PE Ratioverified

ETON

Price:

$57.07

Market Cap:

$1.56B

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-11-14

Stock Exchange

NASDAQ

Ticker

ETON

The PE Ratio as of September 2026 (TTM) for Eton Pharmaceuticals, Inc. (ETON) is 124.07

According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 124.07. This represents a change of 301.40% compared to the average of 30.91 of the last 4 quarters.

Eton Pharmaceuticals, Inc. (ETON) Historical PE Ratio (quarterly & annually)

How has ETON PE Ratio performed in the past?

The mean historical PE Ratio of Eton Pharmaceuticals, Inc. over the last ten years is -44.76. The current 124.07 PE Ratio has changed -27816.31% with respect to the historical average. Over the past ten years (40 quarters), ETON's PE Ratio was at its highest in in the March 2026 quarter at 102.83. The PE Ratio was at its lowest in in the December 2024 quarter at -145.41.

Quarterly (TTM)
Annual

Average

-44.76

Median

-15.24

Minimum

-120.00

Maximum

-3.08

Eton Pharmaceuticals, Inc. (ETON) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.43%

Maximum Annual PE Ratio = -3.08

Minimum Annual Increase = -85.83%

Minimum Annual PE Ratio = -120.00

Quarterly (TTM)
Annual
YearPE RatioChange
2025-99.4712.02%
2024-88.80-26.00%
2023-120.001.43%
2022-7.83-85.83%
2021-55.28804.39%
2020-6.11-13.40%
2019-7.06129.53%
2018-3.08-79.83%

Eton Pharmaceuticals, Inc. (ETON) Average PE Ratio

How has ETON PE Ratio performed in the past?

The current PE Ratio of Eton Pharmaceuticals, Inc. (ETON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-102.76

5-year avg

-74.28

10-year avg

-44.76

Eton Pharmaceuticals, Inc. (ETON) PE Ratio vs. Peers

How is ETON’s PE Ratio compared to its peers?

Eton Pharmaceuticals, Inc.’s PE Ratio is greater than RAPT Therapeutics, Inc. (-29.87), greater than Fulcrum Therapeutics, Inc. (-3.12), greater than Neumora Therapeutics, Inc. Common Stock (-0.61), greater than Lexicon Pharmaceuticals, Inc. (-13.53), greater than Omeros Corporation (9.66), greater than Ocugen, Inc. (-4.08), greater than Monopar Therapeutics Inc. (-43.89), greater than Lineage Cell Therapeutics, Inc. (-7.35), greater than ADC Therapeutics S.A. (-1.60), greater than Bicycle Therapeutics plc (-1.35),

Build a custom stock screener for Eton Pharmaceuticals, Inc. (ETON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eton Pharmaceuticals, Inc. (ETON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Eton Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Eton Pharmaceuticals, Inc. (ETON)?

What is the highest PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?

What is the 3-year average PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?

What is the 5-year average PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?

How does the current PE Ratio for Eton Pharmaceuticals, Inc. (ETON) compare to its historical average?